Blog
Why Lakeland Financial (LKFN) is a Top Dividend Stock for Your Portfolio
All investors love getting big returns from their portfolio, whether it's through stocks, bonds, ETFs, or other types of securities. However, when you're an income investor, your primary focus is
Kimco Realty (KIM) is a Top Dividend Stock Right Now: Should You Buy?
Getting big returns from financial portfolios, whether through stocks, bonds, ETFs, other securities, or a combination of all, is an investor's dream. But when you're an income investor, your
Horace Mann (HMN) Could Be a Great Choice
All investors love getting big returns from their portfolio, whether it's through stocks, bonds, ETFs, or other types of securities. However, when you're an income investor, your primary focus is
Are You Looking for a High-Growth Dividend Stock?
Whether it's through stocks, bonds, ETFs, or other types of securities, all investors love seeing their portfolios score big returns. But for income investors, generating consistent cash flow from
Targa Resources, Inc. (TRGP) is a Top Dividend Stock Right Now: Should You Buy?
Whether it's through stocks, bonds, ETFs, or other types of securities, all investors love seeing their portfolios score big returns. But for income investors, generating consistent cash flow from
Why First Financial Bankshares (FFIN) is a Top Dividend Stock for Your Portfolio
Getting big returns from financial portfolios, whether through stocks, bonds, ETFs, other securities, or a combination of all, is an investor's dream. But when you're an income investor, your
This is Why Exelon (EXC) is a Great Dividend Stock
All investors love getting big returns from their portfolio, whether it's through stocks, bonds, ETFs, or other types of securities. But when you're an income investor, your primary focus is
Citizens Financial Beats Q3 Estimates on Solid NII, Fee Income Growth
Citizens Financial Group CFG reported third-quarter 2025 adjusted earnings per share (EPS) of $1.05, which surpassed the Zacks Consensus Estimate of $1.02 per share. The metric rose 32.9% from the
NVST or ABT: Which Is the Better Value Stock Right Now?
Investors interested in Medical - Products stocks are likely familiar with Envista (NVST) and Abbott (ABT). But which of these two stocks is more attractive to value investors? We'll need to take a
POWL vs. ETN: Which Stock Is the Better Value Option?
Investors interested in Manufacturing - Electronics stocks are likely familiar with Powell Industries (POWL) and Eaton (ETN). But which of these two stocks presents investors with the better value
KMDA or ILMN: Which Is the Better Value Stock Right Now?
Investors with an interest in Medical - Biomedical and Genetics stocks have likely encountered both Kamada (KMDA) and Illumina (ILMN). But which of these two stocks is more attractive to value
CMPGY vs. CAVA: Which Stock Is the Better Value Option?
Investors with an interest in Retail - Restaurants stocks have likely encountered both Compass Group PLC (CMPGY) and Cava Group (CAVA). But which of these two stocks is more attractive to value
SKFRY vs. CNM: Which Stock Is the Better Value Option?
Investors with an interest in Manufacturing - Tools & Related Products stocks have likely encountered both AB SKF (SKFRY) and Core & Main (CNM). But which of these two stocks is more attractive to
JD vs. CHWY: Which Stock Is the Better Value Option?
Investors with an interest in Internet - Commerce stocks have likely encountered both JD.com, Inc. (JD) and Chewy (CHWY). But which of these two stocks presents investors with the better value
OMRNY vs. TEL: Which Stock Is the Better Value Option?
Investors looking for stocks in the Electronics - Miscellaneous Components sector might want to consider either Omron Corp. (OMRNY) or TE Connectivity (TEL). But which of these two stocks is more
DAKT vs. ROK: Which Stock Should Value Investors Buy Now?
Investors looking for stocks in the Electronics - Miscellaneous Products sector might want to consider either Daktronics (DAKT) or Rockwell Automation (ROK). But which of these two stocks presents
TXT vs. RTX: Which Stock Should Value Investors Buy Now?
Investors interested in Aerospace - Defense stocks are likely familiar with Textron (TXT) and RTX (RTX). But which of these two companies is the best option for those looking for undervalued stocks
SR or ATO: Which Is the Better Value Stock Right Now?
Investors looking for stocks in the Utility - Gas Distribution sector might want to consider either Spire (SR) or Atmos Energy (ATO). But which of these two stocks offers value investors a better
LRN or LOPE: Which Is the Better Value Stock Right Now?
Investors with an interest in Schools stocks have likely encountered both K12 (LRN) and Grand Canyon Education (LOPE). But which of these two stocks is more attractive to value investors? We'll need
GO or CL: Which Is the Better Value Stock Right Now?
Investors interested in stocks from the Consumer Products - Staples sector have probably already heard of Grocery Outlet Holding Corp. (GO) and Colgate-Palmolive (CL). But which of these two stocks
General Mills Executes Growth Priorities, Reiterates Outlook
General Mills, Inc. GIS is benefiting from its brand strength, cost savings and portfolio reshaping to enhance market share. The company recently issued an update on the strategic priorities to
Do Options Traders Know Something About Ternium Stock We Don't?
Investors in Ternium S.A. TX need to pay close attention to the stock based on moves in the options market lately. That is because the Nov. 21, 2025 $45.00 Put had some of the highest implied
Can DICK'S Sporting's Digital Strength & Brand Power Aid Growth?
DICK'S Sporting Goods, Inc. DKS continues to leverage its digital strategy as a key growth driver, making bold strides in digital transformation and strengthening position as a leading omnichannel
CORT Files MAA for Relacorilant in Platinum-Resistant Ovarian Cancer
Corcept Therapeutics CORT announced that it has submitted a marketing authorization application (MAA) seeking approval for its lead pipeline candidate, relacorilant, to treat patients with
RCKT Stock Up as FDA Accepts Resubmitted BLA for Gene Therapy
Rocket Pharmaceuticals RCKT announced that the FDA has accepted the resubmitted biologics license application (BLA) seeking approval for its gene therapy Kresladi (marnetegragene autotemcel


